StockData
Vaccinex, Inc. logo

Vaccinex, Inc. (VCNX) stock

VCNXOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q4 FY2024, quarter ended Dec 31, 2024Last filing: 10-K on Apr 15, 2025
$1.00−0.01 (-0.99%)

Close on Oct 19, 2026Market cap $3.22MP/E –Yield –

Vaccinex gross margin

Gross margin is gross profit as a percentage of revenue.

Vaccinex's gross margin for the twelve months ending Dec 31, 2020 was 99.7%. For fiscal 2020 it was 99.7%, against 62.0% the year before.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 202099.7%+37.7
FY2019Dec 31, 201962.0%+104.6
FY2018Dec 31, 2018-42.7%+35.1
FY2017Dec 31, 2017-77.8%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2020Sep 30, 202099.7%+154.8
Q3 FY2019Sep 30, 201998.0%+122.3
Q2 FY2019Jun 30, 201936.0%+131.2
Q1 FY2019Mar 31, 2019-86.2%−69.7
Q4 FY2018Dec 31, 2018-55.2%–
Q3 FY2018Sep 30, 2018-24.2%–
Q2 FY2018Jun 30, 2018-95.2%–
Q1 FY2018Mar 31, 2018-16.5%–

More Vaccinex figures

See a number that looks wrong?